Trial intelligence / Profile preview

Xingbei Zhike granules for post-infectious cough

ChiCTR2000040084Phase 4Not yet recruiting

Sponsor
Guangdong Provincial Hospital of Traditional Chinese Medicine
Start
Jul 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of Xingbei Zhike Granules in postinfectious cough (2 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Area under the curve of visual analogue scale for cough symptoms. Planned start Jul 2020; status: not yet recruiting.

02

Drugs

Xingbei Zhike Granules
03

Conditions

postinfectious cough

Beyond the preview

Go deeper on ChiCTR2000040084.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000040084.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call